Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Colorectal Cancer
  •  Hormone Therapy
  •  Sarcomas
  •  Chemotherapy and Radiotherapy
  •  Lung Cancers
  •  Radiation Oncology
  •  Paediatric Cancers
  •  Endometrial Cancer


Citation: Clin Oncol. 2017;2(1):1199.DOI: 10.25107/2474-1663.1199

B7 Gene Family: Promising Immunotherapeutic Checkpoint in Cancers

Yinxin Zhu, Jing Shen and Zhangang Xiao

Department of Gastroenterology, Soochow University, China
Department of Pharmacology, Southwest Medical University, China

*Correspondance to: Zhangang Xiao 

 PDF  Full Text Short Communication | Open Access


The B7 gene family plays critical roles in regulating adaptive cellular immunity by either costimulating or co-inhibiting T cell functions. And the oncogenic roles of B7 family have already been identified in various cancers, with the immune checkpoint inhibitors of PD-L1/PD-1and CTLA-4/B7 being successfully applied in cancer treatment.


Cite the Article:

Zhu Y, Shen J, Xiao Z. B7 Gene Family: Promising Immunotherapeutic Checkpoint in Cancers. Clin Oncol. 2017; 2: 1199.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Identification of MicroRNAs as New Blood Biomarkers to Predict Breast Cancer Recurrence
 Abstract  PDF  Full Text
CEA and CA19-9 Levels and KRAS Mutation Status as Biomarkers for Colorectal Cancer
 Abstract  PDF  Full Text
View More...